American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Author: Washington, DC.
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Author: Washington, DC.
Beratis, S, Gabriel, J, Hoidas, S (1997). Gender differences in the frequency of schizophrenic subtypes in unselected hospitalized patients. Schizophrenia Research 23, 239–244. doi: 10.1016/S0920-9964(96)00104-1.
Braff, DL, Ryan, J, Rissling, AJ, Carpenter, WT (2013). Lack of use in the literature from the last 20 years supports dropping traditional schizophrenia subtypes from DSM-5 and ICD-11. Schizophrenia Bulletin 39, 751–753.
Conley, RR, Ascher-Svanum, H, Zhu, B, Faries, D, Kinon, BJ (2007). The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophrenia Research 90, 186–197.
Fenton, WS, McGlashan, TH (1991). Natural history of schizophrenia subtypes: I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia. Archives of General Psychiatry 48, 969–977. doi: 10.1001/archpsyc.1991.01810350009002.
First, MB (2010). Clinical utility in the revision of the diagnostic and statistical manual of mental disorders (DSM). Professional Psychology: Research and Practice 41, 465–473.
First, MB, Reed, GM, Saxena, S, Hyman, SE (2015). The development of the ICD-11 clinical descriptions and diagnostic guidelines for mental and behavioral disorders. World Psychiatry 14, 82–90. doi: 10.1002/wps.20189.
Gaebel, W (2012). Status of psychotic disorders in ICD-11. Schizophrenia Bulletin 38, 895–898.
Gaebel, W, Zielasek, J, Cleveland, HR (2012). Classifying psychosis – Challenges and opportunities. International Review of Psychiatry 24, 538–548. doi: 10.3109/09540261.2012.737313.
Green, MF, Kern, RS, Heaton, RK (2004). Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophrenia Research 72, 41–51.
Heilbronner, U, Samara, M, Leucht, S, Falkai, P, Schulze, TG (2016). The longitudinial course of schizophrenia across the lifespan: clinical, cognitive, and neurobiological aspects. Harvard Review of Psychiatry 24, 118–128.
Kay, SR, Opler, LA, Fiszbein, A (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261–276.
Keeley, J, Morton, H, Blashfield, R (2014). Classification. In Oxford Textbook of Psychopathology, 3rd edn (ed. Blaney, P and Millon, T), pp. 42–70. Oxford University Press: New York.
Keeley, JW, Reed, GM, Roberts, MC, Evans, SC, Medina-Mora, ME, Robles, R, Rebello, T, Sharan, P, Gureje, O, First, MB, Andrews, HF, Ayuso-Mateos, JL, Gaebel, W, Zielasek, J, Saxena, S (2016). Developing a science of clinical utility in diagnostic classification systems: field study strategies for ICD-11 Mental and Behavioural Disorders. American Psychologist 71, 3–16. doi: 10.1037/a0039972.
Kendler, KS, Gruenberg, AM, Tsuang, MT (1985). Subtype stability in schizophrenia. American Journal of Psychiatry 142, 827–832.
Kendler, KS, McGuire, M, Gruenberg, AM, Walsh, D (1994). Outcome and family study of the subtypes of schizophrenia in the west of Ireland. American Journal of Psychiatry 151, 849–856.
Mattila, T, Koeter, M, Wohlfarth, T, Storosum, J, van den Brink, W, de Haan, L, Derks, E, Leufkens, H, Denys, D (2015). Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia. Schizophrenia Bulletin 41, 637–643.
Milev, P, Ho, BC, Arndt, S, Andreasen, NC (2005). Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. American Journal of Psychiatry 162, 495–506.
Owen, MJ, Craddock, N, O'Donovan, MC (2010). Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia. Archives of General Psychiatry 67, 667–673.
Peralta, V, Cuesta, MJ (2001). How many and which are the psychopathological dimensions of schizophrenia? Issues influencing their ascertainment. Schizophrenia Research 49, 269–285.
Potuzak, M, Ravichandran, C, Lewandowski, KE, Ongur, D, Cohen, BM (2012). Categorical vs dimensional classifications of psychotic disorders. Comprehensive Psychiatry 53, 1118–1129.
Potvin, S, Ali, A, Stip, E (2007). Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia. Australian and New Zealand Journal of Psychiatry 41, 792–799.
Reed, GM (2010). Toward ICD-11: improving the clinical utility of WHO's international classification of mental disorders. Professional Psychology: Research and Practice 41, 457–464. doi: 10.1037/a0021701.
Reed, GM, Rebello, TJ, Pike, KM, Medina-Mora, ME, Gureje, O, Zhao, M, Dai, Y, Roberts, MC, Maruta, T, Matsumoto, C, Krasnov, VN, Kulygina, M, Lovell, AM, Stona, AC, Sharan, P, Robles, R, Gaebel, W, Zielasek, J, Khoury, B, Mari, J, Ayuso-Mateos, JL, Evans, SC, Kogan, CS, Saxena, S (2015). WHO's Global Clinical Practice Network for mental health. Lancet Psychiatry 2, 379–380. doi: 10.1016/S2215-0366(15)00183-2.
Siskind, D, McCartney, L, Goldschlager, R, Kisely, S (2016). Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systemic review and meta-analysis. British Journal of Psychiatry 209, 385–392. doi: 10.1192/bjp.bp.115.177261.
Tandon, R, Nasrallah, HA, Keshavan, MS (2009). Schizophrenia, ‘Just the facts’ 4. Clinical features and conceptualization. Schizophrenia Research 110, 1–23. doi: 10.1016/j.schres.2009.03.005.
Zachar, P (2000). Psychiatric disorders are not natural kinds. Philosophy, Psychiatry, and Psychology 7, 167–182.